These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 4936279

  • 1. Effects of L-dopa on the H-reflex in parkinsonism.
    Fujita S, Cooper IS.
    J Am Geriatr Soc; 1971 Apr; 19(4):289-95. PubMed ID: 4936279
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. H-reflex in patients with parkinsonism: effect of levodopa.
    Herbison GJ.
    Arch Phys Med Rehabil; 1973 Jul; 54(7):291-5 passim. PubMed ID: 4718235
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of static stretching of the soleus muscle on Hoffman's reflex in parkinsonism; modification of these effects with L-Dopa].
    Krassoievitch M, Gaillard JM, Tissot R.
    Rev Neurol (Paris); 1971 Dec; 125(6):441-7. PubMed ID: 4262887
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B.
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Monosynaptic reflex in patients with Parkinson's disease treated with L-dopa].
    Palao Sánchez A.
    Arch Neurobiol (Madr); 1974 Feb; 37(1):1-10. PubMed ID: 4838663
    [No Abstract] [Full Text] [Related]

  • 9. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
    Birkmayer W, Linauer W, Mentasti M, Riederer P.
    Wien Med Wochenschr; 1974 Jun 01; 124(22):340-4. PubMed ID: 4275492
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].
    Campanella G, Carrieri P, Romito D, Pasqual-Marsettin E.
    Acta Neurol (Napoli); 1973 Jun 01; 28(1):1-34. PubMed ID: 4704396
    [No Abstract] [Full Text] [Related]

  • 12. Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
    Rondot P, Bathien N, Dumas JL.
    Adv Neurol; 1975 Jun 01; 9():373-81. PubMed ID: 1096574
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of L-dopa on the EEG and EMG in Parkinson patients.
    Visser SL, Postma JU.
    Psychiatr Neurol Neurochir; 1971 Jun 01; 74(4):315-21. PubMed ID: 5146237
    [No Abstract] [Full Text] [Related]

  • 15. A year's experience of L-DOPA in the treatment of Parkinson's disease.
    Guidetti B, Giuffrè R.
    Acta Neurochir (Wien); 1971 Jun 01; 24(2):81-8. PubMed ID: 5112463
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. L-dopa and the negative symptoms of Parkinsonism.
    Klawans HL, Erlich M.
    J Neurol Neurosurg Psychiatry; 1969 Oct 01; 32(5):460-1. PubMed ID: 5360053
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.